Skip to content
Rare Disease Tracker
Most Favored Nation Tracker
Rare Disease Tracker
Most Favored Nation Tracker
Methodology
All entries for: BlossomHill Therapeutics
March 2, 2026
BlossomHill Therapeutics
Orphan Drug Designation
San Diego
1-50 employees
treatment of acute myeloid leukemia
Disease Area:
Rare Disease
Source
Scroll to Top